Semler Scientific Inc. (NASDAQ:SMLR) Given Consensus Recommendation of “Moderate Buy” by Analysts

Semler Scientific Inc. (NASDAQ:SMLR) has been assigned an average rating of “Moderate Buy” from the five ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $74.25.

A number of equities research analysts have weighed in on SMLR shares. Benchmark lowered their price objective on Semler Scientific from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Tuesday, September 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Semler Scientific in a research report on Monday, December 29th.

Semler Scientific Trading Down 4.9%

SMLR opened at $20.33 on Friday. The firm’s 50 day moving average is $19.69 and its 200-day moving average is $27.73. Semler Scientific has a 52-week low of $14.89 and a 52-week high of $66.50. The company has a quick ratio of 1.95, a current ratio of 1.97 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $310.74 million, a P/E ratio of 7.31 and a beta of 1.32.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Wednesday, November 12th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of ($0.14) by $1.21. Semler Scientific had a net margin of 130.80% and a return on equity of 34.21%. The business had revenue of $7.49 million during the quarter, compared to the consensus estimate of $7.87 million.

Institutional Investors Weigh In On Semler Scientific

A number of institutional investors have recently modified their holdings of the stock. SummerHaven Investment Management LLC increased its holdings in Semler Scientific by 2.0% in the second quarter. SummerHaven Investment Management LLC now owns 23,570 shares of the company’s stock valued at $913,000 after buying an additional 464 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Semler Scientific by 15.6% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,582 shares of the company’s stock worth $178,000 after acquiring an additional 617 shares in the last quarter. Police & Firemen s Retirement System of New Jersey grew its position in shares of Semler Scientific by 75.5% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 1,674 shares of the company’s stock worth $65,000 after acquiring an additional 720 shares in the last quarter. Cetera Investment Advisers increased its holdings in shares of Semler Scientific by 3.2% in the 2nd quarter. Cetera Investment Advisers now owns 23,376 shares of the company’s stock valued at $906,000 after acquiring an additional 722 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in shares of Semler Scientific by 23.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 4,143 shares of the company’s stock valued at $160,000 after acquiring an additional 776 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.

The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.